Pfizer Inc.

Last updated September 27, 2026

Organization details

Legal name
Pfizer Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
New York
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
December
Ticker symbol
PFE
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000078003
EIN
13-5315170
Wikidata ID
Q206921

Board of directors

Chief executives

Albert Bourla · Chairman & CEO
Since January 2019
55 CEO score

Mixed · grade D

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 50% of the scoring weight is on file.

Dividends 15%
61

dividend grew 3.2% a year

Revenue growth 20%
68

6.3% a year in revenue

Earnings growth 15%
31

-4.5% a year in earnings per share

50% of the scoring weight is on file. Figures cover December 2018 – December 2025.

Director election results

Annual meeting of April 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

7 of this board's directors also sit on 12 other boards.

Network of Pfizer Inc.'s board connections Adobe Inc. Adobe Inc. CarMax Inc CarMax Inc Illumina Inc. Illumina Inc. Intuit Inc. Intuit Inc. NVIDIA Corporation NVIDIA Corporation Tempus AI Inc. Tempus AI Inc. The Bank of New York Mellon Corporation The Bank of New York M... The Boeing Company The Boeing Company The Coca-Cola Company The Coca-Cola Company UnitedHealth Group Incorporated UnitedHealth Group Inc... Unum Group Unum Group W.R. Berkley Corporation W.R. Berkley Corporati... James Quincey James Quincey Johnson Suzanne M. Nora Johnson Suzanne M. N... Joseph Echevarria Joseph Echevarria Mortimer J. Buckley Mortimer J. Buckley Ronald E. Blaylock Ronald E. Blaylock Scott Gottlieb Scott Gottlieb Shantanu Narayen Shantanu Narayen Pfizer Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$2,960,110
3 purchases by 3 insiders
Sold, last 12 months
$134,661
2 sales by 1 insider
Date Insider Transaction Shares Price Value
Aug 12, 2026 Albert Bourla Director, Officer (Chairman & CEO) Open-market purchase +38,000 $26.34 $1,000,920
Aug 5, 2026 Ronald E. Blaylock Director Open-market purchase +39,231 $25.46 $998,821
Aug 5, 2026 Mortimer J. Buckley Director Open-market purchase +37,632 $25.52 $960,369
Aug 5, 2026 DAMICO JENNIFER B. Officer (SVP & Controller) Open-market sale −3,278 $25.40 $83,261
Jun 9, 2026 DAMICO JENNIFER B. Officer (SVP & Controller) Open-market sale −2,000 $25.70 $51,400
Mar 4, 2026 DAMICO JENNIFER B. Officer (SVP & Controller) Shares withheld for tax −826 $26.62 $21,988
Mar 3, 2026 DAMICO JENNIFER B. Officer (SVP & Controller) Grant or award +16,311 — —
Mar 3, 2026 DAMICO JENNIFER B. Officer (SVP & Controller) Grant or award +5,408 — —
Feb 27, 2026 DAMICO JENNIFER B. Officer (SVP & Controller) Shares withheld for tax −655 $27.65 $18,111
Feb 26, 2026 McDermott Michael Officer (Executive Vice President) Shares withheld for tax −3,503 $27.10 $94,931
Feb 25, 2026 SAHNI PAYAL Officer (Executive Vice President) Option exercise +56,888 $33.82 $1,923,952
Feb 25, 2026 LANKLER DOUGLAS M Officer (Executive Vice President) Option exercise +122,907 $33.82 $4,156,715
Feb 25, 2026 DAMICO JENNIFER B. Officer (SVP & Controller) Option exercise +17,558 $33.82 $593,812
Feb 25, 2026 Albert Bourla Director, Officer (Chairman & CEO) Option exercise +491,626 $33.82 $16,626,791
Feb 25, 2026 Lidia Fonseca Officer (Executive Vice President) Option exercise +56,888 $33.82 $1,923,952

Organizations in the same sector, closest in location and size first.

Questions about Pfizer Inc.

Who is the CEO of Pfizer Inc.?

Albert Bourla has been Pfizer Inc.'s Chairman & CEO since January 2019.

How many directors are on Pfizer Inc.'s board?

Pfizer Inc.'s board has 14 directors: Albert Bourla, Cyrus Taraporevala, Dan R. Littman, Helen Hobbs, James C. Smith, James Quincey, Johnson Suzanne M. Nora, Joseph Echevarria, Mortimer J. Buckley, Ronald E. Blaylock and 4 others.

Are Pfizer Inc. insiders buying or selling shares?

Over the last 12 months, Pfizer Inc. insiders bought $3.0 million of shares in 3 purchases and sold $134,661 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="pfizer-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.